Filing Details
- Accession Number:
- 0001144204-11-052179
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-09-09 16:43:45
- Reporting Period:
- 2011-09-06
- Filing Date:
- 2011-09-09
- Accepted Time:
- 2011-09-09 16:43:45
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1175151 | Cytosorbents Corp | CTSO | Surgical & Medical Instruments & Apparatus (3841) | 980373793 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1368153 | David Lamadrid | C/O Cytosorbents Corp. 7 Deer Park Drive, Suite K Monmouth Junction NJ 08852 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2011-09-06 | 12,500 | $0.22 | 7,837,500 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option | Disposition | 2011-09-06 | 12,500 | $0.00 | 12,500 | $0.04 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
7,837,500 | 2011-09-06 | No | 4 | M | Direct |
Footnotes
- The shares of common stock were sold by Mr. Lamadrid pursuant to a 10b5-1 trading plan, adopted by the reporting person on June 8, 2011.
- In addition to the currently outstanding shares of common stock owned by Mr. Lamadrid and reported here, Mr. Lamadrid also beneficially owns the shares of common stock underlying the following stock options: options to purchase 150,000 shares of common stock at $1.90 per share; options to purchase 1,400,000 shares of common stock at $0.25 per share; options to purchase 400,000 shares of common stock at $0.173 per share; options to purchase 400,000 shares of common stock at $0.168 per share, options to purchase 2,750,000 shares of common stock at $0.138 per share; and options to purchase 2,737,500 shares of common stock at $0.035 per share.
- N/A